Orthofix Medical (Orthofix Medical) Days Sales Outstanding

: 55.14 (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

Orthofix Medical's average Accounts Receivable for the three months ended in Dec. 2023 was $121.1 Mil. Orthofix Medical's Revenue for the three months ended in Dec. 2023 was $200.4 Mil. Hence, Orthofix Medical's Days Sales Outstanding for the three months ended in Dec. 2023 was 55.14.

The historical rank and industry rank for Orthofix Medical's Days Sales Outstanding or its related term are showing as below:

OFIX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.02 Med: 58.1 Max: 71.48
Current: 53.84

During the past 13 years, Orthofix Medical's highest Days Sales Outstanding was 71.48. The lowest was 51.02. And the median was 58.10.

OFIX's Days Sales Outstanding is ranked better than
62.95% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.7 vs OFIX: 53.84

Orthofix Medical's Days Sales Outstanding declined from Dec. 2022 (59.16) to Dec. 2023 (55.14).

Orthofix Medical Days Sales Outstanding Historical Data

The historical data trend for Orthofix Medical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

65.29

71.48

59.32

63.94

51.56

Orthofix Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															59.16	51.08	55.05	56.15	55.14

Competitive Comparison

For the Medical Devices subindustry, Orthofix Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orthofix Medical Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Days Sales Outstanding falls into.

Orthofix Medical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Orthofix Medical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (82.857	+	128.098)	/	2 )	/	746.641	*	365
=	105.4775					/	746.641	*	365
=	51.56

Orthofix Medical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (114.118	+	128.098)	/	2 )	/	200.415	*	365 / 4
=	121.108					/	200.415	*	365 / 4
=	55.14

Orthofix Medical (NAS:OFIX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Orthofix Medical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Orthofix Medical (Orthofix Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (NAS:OFIX) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

OM2:Germany

Address

3451 Plano Parkway, Lewisville, TX, USA, 75056

Website

https://www.orthofix.com

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Executives

James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Puja Leekha	officer: CECO & Interim CLO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Geoffrey C Gillespie	officer: VP, Controller, Interim CFO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kevin J. Kenny	officer: President of Global Spine	C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Shweta Maniar	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Stuart Essig	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John J. Bostjancic	officer: CFO	C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Keith Valentine	director, officer: President & CEO	7475 LUSK BLVD., SAN DIEGO CA 92121
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Patrick L Keran	officer: Chief Legal Officer	6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121
Thomas A. West	director	C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Michael E Paolucci	director	7475 LUSK BLVD., SAN DIEGO CA 92121
Catherine M Burzik	director
Rice Doug	officer: CFO	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kimberley A. Elting	officer: Chief Legal Officer	3451 PLANO PARKWAY, LEWISVILLE TX 75056